INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›science›Vivosim Labs Inc. (NASDAQ: VIVS) Uses Human 3D Biology To Streamline Drug Development
science

Vivosim Labs Inc. (NASDAQ: VIVS) Uses Human 3D Biology To Streamline Drug Development

By Info60 UAE Desk•Summary of reporting by Menafn•Sep 22, 2026•0 views•
(MENAFN - GetNews) United States - Sept. 22, 2026 - VivoSim Labs Inc. (NASDAQ: VIVS) is using engineered human tissues to provide pharmaceutical researchers with earlier and potentially more ...
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

ROI & HILM 2027: Verisma Leads Black Book Rankings

Menafn

Edge AI Market Size, Share, Growth, Analysis, Report, 2034

Edge AI Market Size, Share, Growth, Analysis, Report, 2034

Menafn

Sweden Opens Travel Agency For Introverts

Sweden Opens Travel Agency For Introverts

Menafn

APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES

Menafn

French Minister Visits ILBS, Boosts Indo-French Research Collaboration

French Minister Visits ILBS, Boosts Indo-French Research Collaboration

Menafn

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!